Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Zhaoke (guangzhou) Ophthalmology Pharmaceutical Ltd.

Clinical trials sponsored by Zhaoke (guangzhou) Ophthalmology Pharmaceutical Ltd., explained in plain language.

Not yet recruiting 1

Could eye drops replace injections for a leading cause of blindness?

Knowledge-focused Not yet recruiting

This early-stage trial is evaluating the safety, tolerability, and how the body absorbs PAN-90806, an experimental eye drop being developed for wet age-related macular degeneration (AMD), a leading cause of vision loss. Healthy adults aged 18 to 50 will receive either PAN-90806 o…

Phase: PHASE1 • Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. • Aim: Knowledge-focused

Last updated Aug 16, 2026 00:00 UTC